Literature DB >> 2585617

Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.

M K Gospodarowicz1, N V Hawkins, G A Rawlings, J G Connolly, M A Jewett, G M Thomas, J G Herman, P G Garrett, T Chua, W Duncan.   

Abstract

Patients with muscle invasive carcinoma of the bladder treated with radical radiation were prospectively documented and followed in an attempt to identify prognostic factors predictive of the response to treatment. Data on 121 consecutive patients treated with radical radiation between 1981 and 1985 are presented. Over-all actuarial survival of the patient population (median age 70 years) was 31.6% at 5 years and cause-specific survival was 44.8%. At analysis 33 of 121 patients (27.3%) were alive with preserved bladder function. Independent prognostic factors for cause-specific survival and for complete response with radical radiation were tumor configuration, hemoglobin level and clinical stage. The rate free of local relapse was significantly influenced by stage and presence of coexistent carcinoma in situ. The study suggests that factors other than stage and grade influence prognosis in invasive bladder cancer and should be considered in interpreting treatment results.

Entities:  

Mesh:

Year:  1989        PMID: 2585617     DOI: 10.1016/s0022-5347(17)39122-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.

Authors:  Kevin R Kozak; Maryam Hamidi; Matthew Manning; John S Moody
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-06       Impact factor: 7.038

Review 2.  Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.

Authors:  Skyler B Johnson; James B Yu
Journal:  Curr Oncol Rep       Date:  2018-06-30       Impact factor: 5.075

Review 3.  Epidermal growth factor receptor and bladder cancer.

Authors:  A J Colquhoun; J K Mellon
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

4.  Concomitant radiochemotherapy with 5-FU and cisplatin for invasive bladder cancer. Acute toxicity and first results.

Authors:  S Birkenhake; S Leykamm; P Martus; R Sauer
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

Review 5.  [Alternatives to cystectomy].

Authors:  C Niedworok; C Gratzke
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

Review 6.  New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder.

Authors:  P Warde; M K Gospodarowicz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 7.  Chemotherapy for bladder cancer in the elderly.

Authors:  D Raghavan
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

Review 8.  [Therapy and follow-up of bladder cancer].

Authors:  Daniel Meyer; Hans-Peter Schmid; Daniel S Engeler
Journal:  Wien Med Wochenschr       Date:  2007

9.  Effective bladder preservation strategy with low-dose radiation therapy and concurrent intraarterial chemotherapy for muscle-invasive bladder cancer.

Authors:  Hitoshi Ikushima; Seiji Iwamoto; Kyohsuke Osaki; Shunsuke Furutani; Kyoh Yamashita; Takashi Kawanaka; Akiko Kubo; Yoshihiro Takegawa; Takaharu Kudoh; Hiroomi Kanayama; Hiromu Nishitani
Journal:  Radiat Med       Date:  2008-04

10.  Conservative treatment of invasive bladder cancer.

Authors:  N J Rene; F B Cury; L Souhami
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.